We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$584M
AUM Growth
-$30.8M
Cap. Flow
-$1.84M
Cap. Flow %
-0.32%
Top 10 Hldgs %
24.56%
Holding
490
New
13
Increased
6
Reduced
11
Closed
13

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$695K
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$627K
3
SNY icon
Sanofi
SNY
+$579K
4
XOM icon
ExxonMobil
XOM
+$566K
5
VERV
Verve Therapeutics
VERV
+$447K

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$1.44M
2
COHR
Coherent Inc
COHR
+$1.33M
3
CVX icon
Chevron
CVX
+$549K
4
TMUS icon
T-Mobile US
TMUS
+$548K
5
LOW icon
Lowe's Companies
LOW
+$545K

Sector Composition

Rank Sector Weight
1 Technology 24.39%
2 Healthcare 14.9%
3 Financials 13.21%
4 Industrials 11.84%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KR icon
151
Kroger
KR
$35.5B
$919K 0.16%
21,000
– –
ELV icon
152
Elevance Health
ELV
$82.6B
$908K 0.16%
2,000
– –
FWRD icon
153
Forward Air
FWRD
$478M
$903K 0.15%
10,000
– –
XENE icon
154
Xenon Pharmaceuticals
XENE
$6.18B
$903K 0.15%
25,000
– –
TGT icon
155
Target
TGT
$67.9B
$890K 0.15%
6,000
– –
MTDR icon
156
Matador Resources
MTDR
$6.04B
$881K 0.15%
18,000
+6,000
+50% +$324K
BALL icon
157
Ball Corp
BALL
$16.8B
$870K 0.15%
18,000
– –
GILD icon
158
Gilead Sciences
GILD
$164B
$864K 0.15%
14,000
– –
A icon
159
Agilent Technologies
A
$39.3B
$851K 0.15%
7,000
– –
OTIS icon
160
Otis Worldwide
OTIS
$28B
$829K 0.14%
13,001
– –
PLD icon
161
Prologis
PLD
$131B
$829K 0.14%
8,164
– –
MTZ icon
162
MasTec
MTZ
$22B
$826K 0.14%
13,000
– –
THC icon
163
Tenet Healthcare
THC
$20.4B
$825K 0.14%
16,000
– –
CVCO icon
164
Cavco Industries
CVCO
$4.32B
$823K 0.14%
4,000
– –
CAG icon
165
Conagra Brands
CAG
$7.19B
$816K 0.14%
25,000
– –
PDCE
166
DELISTED
PDC Energy, Inc.
PDCE
$809K 0.14%
14,000
+6,000
+75% +$368K
COF icon
167
Capital One
COF
$136B
$805K 0.14%
8,733
– –
CVLG icon
168
Covenant Logistics
CVLG
$906M
$804K 0.14%
56,000
– –
MET icon
169
MetLife
MET
$61.7B
$803K 0.14%
13,216
– –
SKY icon
170
Champion Homes
SKY
$4.61B
$793K 0.14%
15,000
– –
LITE icon
171
Lumentum
LITE
$66.8B
$787K 0.13%
11,475
– –
HRB icon
172
H&R Block
HRB
$5.8B
$766K 0.13%
18,000
– –
SLB icon
173
SLB Ltd
SLB
$75.2B
$764K 0.13%
21,286
– –
SRPT icon
174
Sarepta Therapeutics
SRPT
$1.72B
$763K 0.13%
+6,900
New +$695K
HPQ icon
175
HP
HPQ
$26.3B
$748K 0.13%
30,000
– –
5 6
7
8 9

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2022 Portfolio in Review

As of Q3 2022, NJ State Employees Deferred Compensation Plan held 490 positions worth $584M, down 5% from $614M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2022 filing shows 13 new, 6 increased, 11 reduced and 13 closed positions. Its largest new stake was Sarepta Therapeutics: 6,900 shares worth $763K. The largest sale was Union Pacific, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2022 buy was Sarepta Therapeutics: 6,900 shares worth $763K.
  • NJ State Employees Deferred Compensation Plan added most to ExxonMobil in Q3 2022, an estimated $566K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2022 reduction was Union Pacific, cutting an estimated $1.44M.
  • NJ State Employees Deferred Compensation Plan fully exited Coherent Inc in Q3 2022, selling an estimated $1.33M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $584M portfolio in Q3 2022.
  • NJ State Employees Deferred Compensation Plan opened 13 new positions and closed 13 in Q3 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 5% quarter-over-quarter to $584M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2022, filed 28 Oct 2022.